Literature DB >> 21039862

Escherichia coli pyometra induces transient glomerular and tubular dysfunction in dogs.

B Maddens1, S Daminet, P Smets, E Meyer.   

Abstract

BACKGROUND: Pyometra in dogs has been associated with renal injury. HYPOTHESIS: Examine pyometra-related nephropathy by evaluating novel renal biomarkers. ANIMALS: Twenty-five dogs with Escherichia coli pyometra. Fourteen clinically healthy bitches of comparable age.
METHODS: Prospective study. Urinary biomarkers determined by immunoassays (uIgG, uCRP, uAlb, uRBP, uTXB2) or colorimetric test (uNAG) with results normalized to urine creatinine concentration. Nonparametric Mann-Whitney U-test and Wilcoxon's signed-rank test used to compare healthy dogs and dogs with pyometra, and dogs with pyometra at initial and follow-up examination.
RESULTS: Urinary biomarkers (median, range) significantly increased in dogs with pyometra (uIgG/Cr: 169.7 mg/g, 4.8-1052.9; uCRP/Cr: 0.260 mg/g, 0.006-3.030; uAlb/Cr: 89.5 mg/g, 8.8-832.7; uRBP/Cr: 1.66 mg/g, 0.05-21.44; uNAG/Cr: 5.8 U/g, 1.6-27.7; uTXB2 /Cr: 15.3 μg/g, 3.2-139.6) compared with healthy bitches (uIgG/Cr: 3.4 mg/g, 0.6-8.9; uCRP/Cr: below detection limit; uAlb/Cr: 17.5 mg/g, 1.3-166.3; uRBP/Cr: 0.13 mg/g, 0.02-0.44; uNAG/Cr: 2.4 U/g, 1.4-7.4; uTXB2 /Cr: 2.4 μg/g, 1.2-4.7) (P<.001). Six months after ovariohysterectomy, urinary biomarkers in pyometra group (uIgG/Cr: 4.7 mg/g, 1.5-99.8; uCRP/Cr: below detection limit; uAlb/Cr: 13.9 mg/g, 2.1-471.2; uRBP/Cr: 0.05 mg/g, 0.02-0.32; uNAG/Cr: 1.6 U/g, 0.9-3.3; uTXB2 /Cr: 3.3 μg/g, 1.0-6.9) were significantly lower than before surgery (P<.01), and not significantly different to those of healthy dogs (P>.05). CONCLUSION AND CLINICAL IMPORTANCE: Pyometra-related renal dysfunction affects the nephron both at glomerular and proximal tubular level and is a transient process in most dogs with E. coli pyometra.
Copyright © 2010 by the American College of Veterinary Internal Medicine.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21039862     DOI: 10.1111/j.1939-1676.2010.0603.x

Source DB:  PubMed          Journal:  J Vet Intern Med        ISSN: 0891-6640            Impact factor:   3.333


  6 in total

1.  Warfarin therapy in a dog with acute arterial thrombosis and pyometra.

Authors:  Shiori Arai; Mary Beth Callan
Journal:  Can Vet J       Date:  2014-11       Impact factor: 1.008

2.  Renal function and morphology in aged Beagle dogs before and after hydrocortisone administration.

Authors:  Pascale M Y Smets; Hervé P Lefebvre; Luca Aresu; Siska Croubels; Hendrik Haers; Koen Piron; Evelyne Meyer; Sylvie Daminet
Journal:  PLoS One       Date:  2012-02-29       Impact factor: 3.240

3.  Characterization of Proteinuria in Dogue de Bordeaux Dogs, a Breed Predisposed to a Familial Glomerulonephropathy: A Retrospective Study.

Authors:  Rachel Lavoué; Catherine Trumel; Pascale M Y Smets; Jean-Pierre Braun; Luca Aresu; Sylvie Daminet; Didier Concordet; Florence Palanché; Dominique Peeters
Journal:  PLoS One       Date:  2015-07-16       Impact factor: 3.240

4.  Variability of serum concentrations of cystatin C and urinary retinol-binding protein, neutrophil gelatinase-associated lipocalin, immunoglobulin G, and C-reactive protein in dogs.

Authors:  D J X Liu; E Meyer; B J G Broeckx; S Daminet; J R Delanghe; E Stock; E Bogaerts; M Hesta; K Vanderperren
Journal:  J Vet Intern Med       Date:  2018-09-14       Impact factor: 3.333

5.  Correlation of Urine and Serum Biomarkers with Renal Damage and Survival in Dogs with Naturally Occurring Proteinuric Chronic Kidney Disease.

Authors:  J A Hokamp; R E Cianciolo; M Boggess; G E Lees; S L Benali; M Kovarsky; M B Nabity
Journal:  J Vet Intern Med       Date:  2016-02-01       Impact factor: 3.333

6.  Clinical and ultrasound variables for early diagnosis of septic acute kidney injury in bitches with pyometra.

Authors:  Beatriz Gasser; Ricardo Andres Ramirez Uscategui; Marjury Cristina Maronezi; Letícia Pavan; Ana Paula Rodrigues Simões; Fernanda Martinato; Priscila Silva; Leandro Zuccolotto Crivellenti; Marcus Antônio Rossi Feliciano
Journal:  Sci Rep       Date:  2020-06-02       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.